CLEVELAND, May 13, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today reported financial results for the first quarter of 2026, highlighting commercial momentum for ZEVASKYN.

(OTCID: TGNT) (“Totaligent” or “the Company”), an emerging leader in specialized infrastructure platform for the blossoming biologics space and intelligent business marketing data, today announced the ...

Brenntag (ETR:BNR) said its first-quarter 2026 results reflected a slow start to the year followed by a sharp improvement in ...

Education Minister Dharmendra Pradhan urged industry leaders to support government schools, expand vocational learning, and ...

Three patients treated with ZEVASKYN- in Q1 2026 - - QTC network expands to six sites, with two new additions on the East Coast - - In-licensed radically novel engineered T-cell technology with game ...

Wang Chuanfu is the founder, chairman and CEO of the BYD Company. He is one of the most remarkable entrepreneurs of the twenty-first century.

Team One’s 2026 Global Affluent Collective report finds 49% of the world’s wealthiest still feel limited—revealing a ...

Bioretec Ltd Company release 13 May 2026 at 14:00 p.m. EEST Bioretec clarifies its 2026-2028 financial target regarding the sales marginTo be aligned with industry reporting standards, Bioretec will ...